Corporate social responsibility
Corporate Social Responsibility (CSR)
Being socially responsible is at the core of how we do business at Genmab and is reflected in Genmab’s core values. We believe in the idea that a company has a responsibility to conduct itself in a way that benefits not only the company’s main stakeholders, in our case patients, shareholders and employees, but also society as a whole.
At Genmab we strive to comply with all relevant laws, standards and guidelines. We seek to create new medicines to help patients, with a focus on cancer. We consider the well-being of our employees a top priority and we minimize our impact on the environment as much as we can. We have high ethical standards and aim to conduct business with companies and within countries which share our ethics. We do not conduct business in high risk countries where human rights are not upheld. Due to the fact that we have a limited number of employees and therefore carefully allocate our resources, we have chosen not to implement a specific human rights policy. However, Genmab supports and respects the protection of internationally proclaimed human rights through other policies which address responsible supply chain management, ethical procedures, health and safety procedures and issues regarding access to medicine. In addition, Genmab only conducts clinical trials in markets where a drug is planned to become available.
Our CSR Committee, comprised of representatives from our human resources, investor relations & communications, legal, finance and research & development functions, ensures that Genmab carries out these activities effectively and communicates clearly and openly about our CSR initiatives.
Genmab’s CSR report discloses the main highlights of our CSR initiatives but does not reflect all of our ongoing initiatives and procedures. As part of our commitment to CSR we monitor new developments and practices and consider new initiatives which could further enhance our CSR activities.
Click the link below to access Genmab’s statutory report on CSR for the financial year 2016 cf. Section 99a of the Danish Financial Statements Act (“Lovpligtig redegørelse for samfundsansvar, jf. årsregnskabslovens § 99 a”), including additional information about policies, progress made during 2016 and expected activities for 2017.
CSR Report 2016 - English
Policy regarding the Proportion of Gender in other Management Levels of the Genmab group:
Genmab is committed to continue working towards and maintaining equal opportunities for women and men at all management levels in the Genmab group. Genmab encourages talented male and female employees to pursue a career in the company. Genmab regularly conducts employee surveys and employee development interviews to identify barriers – or the perception of barriers – preventing equal opportunities for men and women. In connection with recruitment, including recruitment at management level, it is the policy of the Genmab group to meet the company's needs for employees with the right skills and competences, regardless of gender, age, ethnicity, etc. When choosing between equally qualified candidates, the diversity among the employees shall be taken into consideration, as it is the aim that both genders attain a representation at management levels of at least 40%. In connection with recruitment for managerial positions it must be ensured, where possible, that the candidates invited for interview include both men and women. The company's focus on diversity among its employees, including at management levels, must be visible during recruitment.
The policy may be amended by the Board of Directors and should be interpreted in accordance with applicable equal rights and anti-discrimination legislation in Denmark, in force from time to time.
A Target Figure for the Number of Women in the Board of Directors of Genmab A/S has been established. Click here for more information.